Clinical Trials

18 enrolled

Thyroid Neoplasms

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

120 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07470489 2026-04-16

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

12 enrolled

Thyroid Carcinoma, Anaplastic

NCT07532538 2026-04-16

ML-HNC-Risk

3,000 enrolled

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT07172256 2026-04-15

CUE-101with Pembrolizumab for LA-HPV+HNSCCs

Squamous Cell Carcinoma of Head and Neck

NCT07485569 2026-04-15

REPOTHYROID-II

10 enrolled

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT07524894 2026-04-15

SNIFF

126 enrolled

Head and Neck Neoplasms

NCT07531563 2026-04-15

C-Head-002

504 enrolled

Head and Neck Neoplasms

NCT07532356 2026-04-15

Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients

100 enrolled

Thyroid Neoplasms

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

BreastGastrointestinalGenitourinaryHead & Neck

300 enrolled

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

DermatologicEndocrineGenitourinaryHead & Neck

142 enrolled

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT07529769 2026-04-14

AID-OraL

5,000 enrolled

Squamous Cell Carcinoma of Head and Neck, Disease, Mouth Neoplasms

NCT07529873 2026-04-14

N'FORCE

131 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07156227 2026-04-13

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07407582 2026-04-13

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

25 enrolled

GenitourinaryHead & Neck

Head and Neck Neoplasms, Neoplasms, Testicular Neoplasms, Hearing Loss

NCT07521670 2026-04-13

STRAP

68 enrolled

Thyroid Cancer, Papillary, Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT07524413 2026-04-13

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

514 enrolled

Nasopharyngeal Neoplasms

NCT07524777 2026-04-13

Ganoderma Spores Modulate the Gut-Brain Axis

300 enrolled

Depression, Thyroid Neoplasms

NCT07419464 2026-04-09

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

46 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

NCT07518485 2026-04-08

preReDSeL

20 enrolled

Mouth Neoplasms

NCT07488585 2026-04-07

THYMAL 01

Thyroid Diseases, Thyroid Nodule

NCT07513324 2026-04-07

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

116 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07513389 2026-04-07

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

36 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT07514767 2026-04-07

NOCANO

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07441681 2026-04-03

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

454 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07509099 2026-04-03

Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC

316 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07264075 2026-04-02

ILLUMINE

780 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07507058 2026-04-02

Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07247201 2026-03-30

AlloNK1

31 enrolled

Nasopharyngeal Carcinoma, Neoplasm, Residual

NCT07497607 2026-03-27

REDUCE-30

31 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05108870 2026-03-25

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

98 enrolled

Head and Neck Neoplasms

NCT07492914 2026-03-25

Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma

Head and Neck Neoplasms

NCT07241273 2026-03-24

SELECT-FR

128 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT07491783 2026-03-24

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

52 enrolled

Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Sarcoma

NCT07320963 2026-03-20

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

52 enrolled

Nasopharyngeal Carcinoma

NCT07466810 2026-03-20

Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology

Mouth Neoplasms

NCT07484139 2026-03-20

NEO COMBAT XL

26 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06876038 2026-03-19

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

65 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Leukoplakia, Oral, Mouth Neoplasms, Lichen Planus, Oral

NCT07471451 2026-03-16

RMF-CROC

50 enrolled

Head and Neck Neoplasms

NCT07471009 2026-03-13

SPAR

120 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

10 enrolled

BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

NCT07460765 2026-03-10

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

40 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms, Squamous Cell

NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

85 enrolled

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07453472 2026-03-06

PDT CALCI HOL

166 enrolled

Leukoplakia, Oral

NCT07303283 2026-03-05

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

218 enrolled

Nasopharyngeal Carcinoma

NCT07453225 2026-03-05

Empirical Radioactive Iodine Therapy in DTC

100 enrolled

Differentiated Thyroid Cancer

NCT07179315 2026-03-04

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

68 enrolled

Head and Neck Neoplasms

NCT07445048 2026-03-03

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Bemcentinib in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

370 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07193186 2026-02-27

Anlotinib and Benmelstobart in DTC

23 enrolled

Thyroid Neoplasms

NCT07217028 2026-02-27

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

60 enrolled